Adrenocortical carcinoma, Endocr. Rev, vol.35, pp.282-326, 2014. ,
Integrated genomic characterization of adrenocortical carcinoma, Nat. Genet, vol.46, pp.607-612, 2014. ,
Genomic landscape of paediatric adrenocortical tumours, Nat. Commun, vol.6, 2015. ,
Comprehensive pan-genomic characterization of adrenocortical carcinoma, Cancer Cell, vol.29, pp.723-736, 2016. ,
FATE1 antagonizes calcium-and drug-induced apoptosis by uncoupling ER and mitochondria, EMBO Rep, vol.7, pp.1264-1280, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02108682
Synthetic lethal screen identification of chemosensitizer loci in cancer cells, Nature, vol.446, pp.815-819, 2007. ,
Comprehensive functional characterization of cancer-testis antigens defines obligate participation in multiple hallmarks of cancer, Nat. Commun, vol.6, 2015. ,
EWSR1-FLI1 activation of the cancer/testis antigen FATE1 promotes Ewing sarcoma survival, Mol. Cell. Biol, vol.39, pp.138-157, 2019. ,
Cancer/testis antigens, gametogenesis and cancer, Nat. Rev. Cancer, vol.5, pp.615-625, 2005. ,
Cancer-testis antigen peptide vaccine for cancer immunotherapy: Progress and prospects, Transl. Oncol, vol.12, pp.733-738, 2019. ,
Identification of two novel CT antigens and their capacity to elicit antibody response in hepatocellular carcinoma patients, Br. J. Cancer, vol.89, pp.291-297, 2003. ,
Immunohistochemical analysis of the expression of FATE/BJ-HCC-2 antigen in normal and malignant tissues, Lab. Invest, vol.85, pp.205-213, 2005. ,
Prognostic significance of Major Histocompatibility Complex Class II expression in pediatric adrenocortical tumors: A St. Jude and Children's Oncology Group study, Clin. Cancer Res, vol.22, pp.6247-6255, 2016. ,
, The immune landscape of cancer. Immunity, vol.48, pp.812-830, 2018.
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): Results from The Cancer Genome Atlas (TCGA), J. Immunother. Cancer, vol.6, 2018. ,
Molecular drivers of potential immunotherapy failure in adrenocortical carcinoma, J. Oncol, 2019. ,
Programmed death ligand-1 expression in adrenocortical carcinoma: An exploratory biomarker study, J. Immunother. Cancer, vol.3, issue.3, 2015. ,
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: Phase 1b results from the JAVELIN solid tumor trial, J. Immunother. Cancer, vol.6, p.111, 2018. ,
Immunotherapy failure in adrenocortical cancer: Where next?, Endocr. Connect, vol.7, pp.5-8, 2018. ,
The prognostic role of CD8 + T lymphocytes in childhood adrenocortical carcinomas compared to Ki-67 ,
URL : https://hal.archives-ouvertes.fr/inserm-02437545
PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma, Oncoimmunology, vol.8, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02509464
, , 2020.
Pediatric adrenocortical tumors: What they can tell us on adrenal development and comparison with adult adrenal tumors, Front. Endocrinol, vol.6, 2015. ,
Increased Steroidogenic Factor-1 dosage triggers adrenocortical cell proliferation and cancer, Mol. Endocrinol, vol.21, pp.2968-2987, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00172059
Impact of ACTH signaling on transcriptional regulation of steroidogenic genes, Front. Endocrinol, 2016. ,
SF-1 overexpression in childhood adrenocortical tumours, Eur. J. Cancer, vol.42, pp.1040-1043, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00172257
Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults, J. Clin. Endocrinol. Metab, vol.95, pp.1458-1462, 2010. ,
High diagnostic and prognostic value of Steroidogenic Factor-1 expression in adrenal tumors, J. Clin. Endocrinol. Metab, vol.95, pp.161-171, 2010. ,
Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy, Clin. Chim. Acta, vol.421, pp.213-218, 2013. ,
Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy, Kidney Int, vol.95, pp.666-679, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02380896
The most N-terminal region of THSD7A is the predominant target for autoimmunity in THSD7A-associated membranous nephropathy, J. Am. Soc. Nephrol, vol.29, pp.1536-1548, 2018. ,
Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling, Clin. Cancer Res, vol.15, pp.668-676, 2009. ,
Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival, J. Clin. Oncol, vol.27, pp.1108-1115, 2009. ,
PTTG1 overexpression in adrenocortical cancer is associated with poor survival and represents a potential therapeutic target, Surgery, vol.154, pp.1405-1416, 2013. ,
Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics. REporting recommendations for tumour MARKer prognostic studies (REMARK), Br. J. Cancer, vol.93, pp.387-391, 2005. ,